Amy McBride Wendell

Director, Axogen, Inc.; Director, Solventum

Bought, 12 months

$0.1M

Sold, 12 months

$2.0M

Companies

Latest trade

Aug 11, 2026

Companies

Axogen, Inc.Director −$2.0M SolventumDirector +$0.1M

Trades

AXGN Sold 13,353 shares at $48.42 · planned $0.6M Aug 11

AXGN Sold 1,647 shares at $42.60 $0.1M May 8

SOLV Bought 1,475 shares at $68.03 $0.1M Mar 10

AXGN Sold 43,684 shares at $29.31 $1.3M Dec 16

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.